Close Menu

NEW YORK (GenomeWeb) – Recurrent translocations involving the immunoglobulin lambda (IgL) antibody locus may provide previously unappreciated clues to treatment response and patient outcomes in multiple myeloma, according to new research from an Emory University-led team.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.